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Abstract 
Purpose: To synthesise and evaluate the anti-tumour properties of doxorubicin-loaded xanthan gum-
functionalised cobalt ferrite nanoparticles (CoFe2O4.NPs@XG-Doxo) under an AC-magnetic field. 
Methods: Multidimensional magnetic cobalt ferrite (CoFe2O4) nanoparticles (NPs) were synthesised by 
a co-precipitation method. The synthesised cobalt ferrite nanoparticles (CFNPs) were functionalised 
with xanthine gum (XG) and subsequently characterised by Fourier transform-infrared spectroscopy 
(FT-IR), thermogravimetric analysis (TGA) and contact angle studies. Vibrating sample magnetometry 
(VSM) was used for magnetic measurements of the native and XG-coated CFNPs. The microstructural 
morphology of the uncoated and XG-coated CFNPs was established using scanning electron 
microscopy (SEM), atomic force microscopy (AFM) and dynamic light scattering (DLS) studies. Finally, 
the doxorubicin release profile of the drug-loaded functionalised CFNPs was evaluated using an 
oscillating magnetic field (OMF) apparatus in the presence of an externally applied magnetic field. 
Results: XG coating decreased the contact angle of the native CFNPs from 92° to 40°, which indicates 
that it modified the CFNP surface from hydrophobic to hydrophilic. VSM analysis demonstrated that 
CoFe2O4.NPs@XG also retained the magnetic characteristics of the bare cobalt ferrite nanocrystals, 
endorsing its application as a promising magnetic nanovector (MNV). The synthesised 
CoFe2O4.NPs@XG-Doxo exhibited significantly higher controlled discharge of doxorubicin at acidic pH 
(5.0) than at neutral pH (7.4). In vitro analysis revealed the remarkable lower systematic toxicity of XG-
coated CoFe2O4.NPs compared with uncoated CFNPs against Chinese hamster ovary (CHO) and Huh7 
cell lines. 
Conclusion: These results indicate that XG-coated CFNPs are a biocompatible MNV for doxorubicin. 
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Various nanosystems have been proposed to 
increase their implementation in several 
biological fields, such as cancer therapy, 
pharmaceuticals and tissue engineering [1]. In 
particular, spinel ferrites (MFe2O4, M = Fe+2, 
Zn+2, Mn+2, Co+2 or Ni+2) are promising magnetic 
products for many biomedical applications. 
Cobalt ferrite nanoparticles (CFNPs) are suitable 
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for magnetic resonance imaging (MRI) and 
targeted drug delivery (TDD) because of their 
tunable coercivity and excellent saturation 
magnetisation (Ms) [2]. There are various routes 
to prepare CFNPs, such as via combustion [3], 
microemulsions with oil-in-water micelles [4], 
reverse micelles [5], co-precipitation and 
calcination [6], sol-gels [7], microwaves [8] and 
forced hydrolysis in a polyol medium [9]. 
 
However, biomedical applications of native 
CFNPs are restricted because of their 
hydrophobic surface. Most of the plasma proteins 
are hydrophobic, which enables the rapid 
removal of hydrophobic nanostructures from the 
blood circulatory system through opsonisation 
[10]. Previously, nanoferrite functionalization was 
carried out by coating with proteins, polymers, 
surfactants, starch or chitosan [11]. We report 
herein the first investigation of encapsulating 
CFNPs with xanthan gum (XG), which is an 
anionic polysaccharide that coats the cationic 
surface of the NPs. The biocompatibility of XG 
suggests a broad range of applications in the 
biomedical arena [12].  
 
Herein, we report the synthesis and 
characterisation of XG-coated CFNPs 
(CoFe2O4.NPs@XG) to enhance application as a 
biocompatible magnetic nanovector (MNV) for 
targeted delivery of the anti-tumour drug 
doxorubicin (Doxo). The release of drug from 
CoFe2O4.NPs@XG-Doxo was determined in the 
absence as well as in the presence of an 
externally applied magnetic field (AMF). The 
cytocompatibility and toxicity of the naked and 
XG-coated ferrite NPs toward Chinese hamster 







Cobalt (II) chloride hexahydrate (CoCl2·6H2O; 
Alfa Aesar, 98 % purity), iron (III) chloride 
hexahydrate (FeCl3·6H2O; Sigma–Aldrich, ACS 
reagent grade, 97 % purity), potassium hydroxide 
(KOH; Alfa Aesar, 98 % purity), ethanol 
(C2H5OH; Sigma–Aldrich) and doxorubicin 
hydrochloride (Sigma–Aldrich) were used as 
received. Double-distilled deionised water was 
used as solvent.  
 
Synthesis of the CFNPs 
 
The CFNPs were synthesised using a previously 
reported method with minor modifications [13]. 
Briefly, aqueous solutions of ferric chloride (0.4 
M, 25 mL) and cobalt chloride (0.2 M, 25 mL) 
were mixed and stirred in a three-necked flask at 
pH 1.34. Precipitation occurred immediately as 3 
M KOH solution was slowly added drop-wise 
under an inert atmosphere of nitrogen gas. Then, 
the reaction temperature was increased to 85 °C 
and stirring was maintained for 90 min. The 
resulting dark black precipitate was decanted 
using a strong permanent magnet, washed 
multiple times with distilled water and finally 
oven-dried at 100 °C for 12 h. The synthesised 
cobalt ferrite nanocrystals were dialysed for 8 h 
in 100 mL of 0.02 M HNO3 solution to form a 
cationic charge over the surface, dried and 
stored at 4 °C for further functionalization. 
 
Synthesis of MNV (CoFe2O4.NPs@XG) 
 
XG-coated CFNPs (CoFe2O4.NPs@XG) were 
prepared by dispersing the dialysed cobalt ferrite 
nanocrystals in distilled water, mixing with XG at 
a 1:2 ratio and stirring for 24 h. The supernatant 
layer was discarded and the resulting dark brown 
coated cobalt ferrite nanocrystals were washed 
with distilled water and finally freeze-dried for 
further studies. 
 
In vitro drug loading and release studies  
 
The prepared MNV (CoFe2O4.NPs@XG) was 
loaded with Doxo by dissolving 10 mg of dried 
CoFe2O4.NPs@XG in 25 mL of a drug solution 
(0.2 mg/mL) at room temperature and gently 
stirring for 2 days in the dark. The drug solution 
was prepared in phosphate-buffered solution 
(PBS) at pH 7.4. Thereafter, the drug-loaded 
magnetic nanoassembly, CoFe2O4.NPs@XG-
Doxo, was separated using a magnet, washed 
several times with PBS and finally freeze-dried. 
The supernatant and washed solutions were 
collected and analysed to determine the 
unloaded drug concentration by UV-visible (UV-
Vis) spectroscopy at a wavelength of 481 nm. 
The drug loading efficiency (L) was calculated 
using Eq 1. 
 
L (%) =  ………………… (1) 
 
where Co is the total amount of the added drug 
and C is the unencapsulated amount of drug. 
 
To determine the drug release profile, 6 mg of 
the drug-loaded MNV (CoFe2O4.NPs@XG) was 
sealed in a porous dialysis bag having a 
molecular weight cut-off (MWCO) of 10 kDa 
(Millipore). Thereafter, the dialysis bag was 
suspended in 40 mL of sterile phosphate-
buffered solution having pH 7.4 and 5.0 
separately at 37 °C under gentle orbital shaking 
(120 rpm/min). At designated time intervals (1, 2, 
4, 6, 8, 10, 12, 24, 36, 48, 20, 24, 36, 48, 60, 72, 
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84, 96, 108 and 120 h), 2 mL of dialysate was 
withdrawn from the dialysis bag to determine the 
released drug concentration. The withdrawn 
volumes of dialysate were returned to the release 
medium to reconstitute the original volume of 
PBS. In a similar fashion, the drug release 
experiment was repeated when the drug release 
system was placed in a 40-mL glass tube in the 
presence of an external oscillating magnetic field 
(OMF) (ca. 1000 Oe) generated by a custom-
made instrument called a Teslamate. This device 
(Figure 1) consisted of 96 turns of a 76.5-mm 
length of 0.8-mm-diameter copper wire that 
operated over a frequency of 1–500 kHz at a 
current of 1–3 amperes and a magnetic flux 




The CHO and Huh7 cell lines were provided by 
the Centre of Excellence and Molecular Biology 
(CEMB), Lahore, Pakistan. To obtain culture 
growth, the cell lines were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10 % foetal bovine serum 
(FBS) and incubated at 37 °C under a humidified 
atmosphere containing 5 % CO2. The cells lines 
were routinely harvested by adding 0.25 % 
trypsin–ethylenediaminetetraacetic acid (EDTA) 
solution. 
 
Cytotoxicity of the MNV (CoFe2O4.NP@XG) 
 
To analyse the in vitro cytotoxicity of the bare 
and coated cobalt ferrite NPs against CHO and 
Huh7, cells were harvested in 96-well plates at a 
density of 10,000 cells per well. Different 
concentrations of native CoFe2O4.NPs and 
CoFe2O4.NPs@XG (0–2.0 mg/mL) were added 
to each well, in duplicate. Thereafter, the culture 
plate was incubated at 37 °C in humidified air 
containing 5 % CO2 for 48 h. After culturing 
sufficient cells, the medium in all wells was 
exchanged with fresh medium. Finally, the 
standard MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) assay was used to 
measure the cell viability relative to that of the 
control untreated cells. 
 
In vitro cytotoxicity of the magnetic 
nanoassembly (CoFe2O4.NPs@XG-Doxo) 
 
The in vitro cytotoxicity of the drug-loaded 
magnetic nanoassembly, CoFe2O4.NPs@XG-
Doxo, was tested against the Huh7 cell line by 
MTT assay. Briefly, 1 × 104 cells/well were 
harvested in a 96-well plate and incubated at 37 
°C with humidified air containing 5 % CO2 for 24 
h. Then, different concentrations (0–0.20 mg/mL) 
of the drug-loaded magnetic nanoassembly were 
added to each well medium, in triplicate, and 
incubated in 5 % CO2 humidified air at 37 °C for 




The UV-vis spectra of the pure 
cobalt ferrite NPs were recorded in the range of 
100–600 nm using a spectrometer (model UV-
2600; Shimadzu, Japan). The drug loading and 
release profile was also obtained with the same 
instrument at 481 nm. 
 
Fourier transform-infrared (FT-IR) 
spectroscopy 
 
The FT-IR spectra of the cobalt ferrite NPs and 
its nanocomposites were recorded on a 
spectrophotometer (model 983; Perkin-Elmer, 
USA) using the KBr technique in the range of 




Figure 1: Teslamate used to generate oscillating magnetic field (OMF) for drug release studies 
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Thermogravimetric analysis (TGA) 
 
The thermal properties of the native cobalt ferrite 
NPs and the weight percentage of XG coated on 
the NPs were determined by TGA (model TGA-
50; Shimadzu, Japan) over the range of 20 – 800 
°C. 
 
Contact angle measurements 
 
The contact angles of uncoated and XG-coated 
cobalt ferrite NPs were measured using a contact 
angle meter with the sessile drop method (model 
HO-ED-M-01, Holmarc Opto-Mechatronics, 
India). 
 
X-ray diffraction (XRD) studies 
 
XRD patterns were measured with a 
diffractometer (model 6000; Shimadzu, Japan) in 
the 2 range of 5–70° using Ni-filtered Cu-K 
radiation. The crystallite size was determined 
from the broad diffraction plane (311) using the 
Debye–Scherer equation (Eq 2) [14]: 
 
D =  …………… (2) 
 
where k is a constant (0.9), β is the full-width at 
half-maximum (FWHM) of the high-intensity 
diffraction peak corresponding to the (311) plane, 
λ is the wavelength of the Cu Kα radiation (1.54 
Å) and θ is the Bragg angle. 
 
Vibrating sample magnetometry (VSM) 
 
The magnetic potential of coated and uncoated 
CoFe2O4.NPs was evaluated using a vibrating 
sample magnetometer (model 7404; Lake Shore 
Cryotronics, USA) at 300 K at an AMF ranging 




The microstructures of prepared samples were 
studied by scanning electron microscopy (SEM; 
model TM-1000; Hitachi, Japan). Atomic force 
microscopy (AFM; Park NX10, Korea) was used 
to measure the size of native and coated ferrite 
particles dispersed in hexane. The hydrodynamic 
diameter and polydispersity index (PDI) of a 
sample was measured by dynamic light 






The successful synthesis of the cobalt ferrite NPs 
by co-precipitation was initially confirmed by UV-
Vis spectroscopy. The nanoferrite spectra 
displayed a characteristic shoulder band in the 
range of 330–500 nm that was attributed to their 
synthesis [15] (Figure 2). 
 
 
Figure 2: UV-visible spectrum of native cobalt 
ferrite NPs (CoFe2O4.NPs) 
 
Attenuated total reflectance (ATR) FT-IR 
spectra 
 
The CFNPs and their XG-coated derivative 
(CoFe2O4.NPs@XG) were investigated by ATR 
FT-IR spectroscopy. Figure 3 shows the spectra 
of the uncoated and coated CFNPs. The 
characteristic spinel-phase peaks of native cobalt 
ferrite NPs observed at 610 and 492 cm−1 were 
attributed to the intrinsic vibration of (M–O)th  and 
(M–O)oh sites, respectively [16]. The splitting of 
the low-frequency band at the octahedral (B) site 
revealed the presence of different metal ions 
including Fe3+, Fe2+ and Co2+. The broad 
absorption band at 3350−3500 cm−1 was 
assigned to the stretching vibration of the –OH 
group. Figure 3b shows the presence of the 
ferrite spinel lattice band at 400–600 cm−1, which 
confirmed the coating of XG over the ferrite NPs. 
The additional bands at 1447 and 1072 cm−1 
correspond to the M–O–C linkage (M = Co, Fe) 
[17]. Various quinone and ketone carbonyl peaks 
confirmed the loading of Doxo onto the coated 
CFNPs (Figure 3c). The splitting of the 2950–
3250 and 1547 cm−1 peaks correspond to the 
N−H stretching and N−H bending vibrations, 
respectively, of the secondary amide group. In 
brief, the FT-IR spectrum of the loaded drug 
(Figure 3c) revealed the drug adsorption in two 
ways: first, by partial interaction between the XG 
carboxylate (COO−) and amine (–NH2) groups of 
the drug via amide formation and, second, by the 
–OH vibrational bands. 
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Figure 3: ATR-FTIR spectrums of (a) pure CFNPs; (b) xanthan gum coated (CoFe2O4.NPs@XG); and (c) 




Thermal analysis of the uncoated and coated 
CFNPs was performed from 25 to 800 °C to 
obtain quantitative evidence of the nanoferrite 
coating. The TGA curves of the pure and XG-
coated ferrite NPs displayed different thermal 
behaviours (Figure 4). The percentage weight 
loss of the uncoated ferrite nanocrystals was just 
3 % over the range of 20 – 200 °C. However, the 
XG-coated CFNPs exhibited a ca. 8% mass loss 
below 150°C, which increased to ca. 16 % from 
150 to 380 °C. 
Contact angle  
 
The wettability and surface interactions of the 
coated and uncoated CFNPs with water were 
determined by contact angle measurements. 
CFNPs should be hydrophilic for biomedical 
applications. Figure 4 shows the sessile water 
droplet (2 μL) contact angles over thick solid 
sample surfaces. The contact angles of the 
native and XG-coated ferrite NPs were 92.40° 
and 39.90°, respectively (Figure 5 (a, b)).  
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Figure 4: Thermogravimetric curves for native (CoFe2O4.NPs) and xanthan gum coated cobalt ferrite 
nanoparticles (CoFe2O4.NPs@XG) 
 
            
Figure 5: Contact angle images of (a) uncoated CoFe2O4.NP; (b) XG-coated cobalt ferrite NPs 





Figure 6: XRD patterns of (a) uncoated CoFe2O4.NPs 
and (b) xanthan gum-coated CoFe2O4.NPs@XG (b) 
 
Figure 6 shows the XRD patterns of the 
uncoated (CoFe2O4.NPs) and XG-coated 
(CoFe2O4.NPs@XG) CFNPs. For the uncoated 
case, the (111), (220), (311), (222), (400), (422), 
(511) and (440) diffraction planes corresponded 
to angles of 18.29°, 30.08°, 35.44°, 37.06°, 
43.06°, 53.45°, 56.98° and 62.59°, respectively. 
The indexed values of the uncoated CFNPs were 
in agreement with the Joint Committee on 
Powder Diffraction Standards (JCPDS) data card 
no. 22-1086 for the inverse spinel structure 
having a cubic geometry. The same 
characteristic XRD peaks were also observed for 
the XG-coated CFNPs (Figure 6 (b)), also 
indicating the single-phase spinel structure for 
the coated sample. The average crystal size (D) 




SEM, AFM and DLS were used to investigate the 
microstructure of the uncoated and XG-coated 
CFNPs. SEM images (Figure 7 (a, b)) reveal the 
elongated, oval-shaped morphology of the native 
ferrite NPs. The average size of the native and 
coated CFNPs ranged from 20 to 60 nm. 
Topographical images of the uncoated and 
coated CoFe2O4.NPs are shown in Figure 8 (a, 
b). Furthermore, the 3-D AFM image (Figure 8c) 
confirmed the oval-shaped texture of the 
uncoated CFNPs, as previously noted [18]. DLS 
measurements (Figure 9) established a PDI of 
less than 0.16 and a nanosized range for all of 
the prepared samples [9]. 
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Figure 7: SEM images of uncoated (a); and XG-coated Cobalt ferrite NPs (b) 
 




Figure 8: Topographical AFM images of (a) uncoated; (b) XG-coated Cobalt ferrite NPs; (c) 3D AFM image of 
native CoFe2O4.NPs 
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The magnetic properties of the uncoated and 
XG-coated CFNPs were measured by VSM at 
room temperature. Figure 10 shows the 
magnetisation as a function of the applied field 
(M–H curves) of the coated and uncoated 
CFNPs for magnetisation varying from −15 to 15 
kOe. VSM study produced Ms values of 62.55 
and 50.27 emu/g for the uncoated and coated 
CFNPs, respectively. A suspension of pure 
CFNPs showed a strong attraction toward a 
magnetic field (Figure 11). 
 
Drug release profile 
 
The anti-tumour drug release profile of the drug-
loaded MNV was determined in the absence and 
presence of an external AMF. The Doxo 
encapsulation efficiency of the 
CoFe2O4.NPs@XG MNV was ca. 83 %, which is 
greater than previously reported [19]. Wong et al. 
reported an average encapsulation efficiency of 
ca. 70 % for Doxo on solid lipid nanoparticles 
(SLNs) [20]. The drug release behaviour of the 
MNV was studied for 120 h in phosphate-
buffered saline (0.1 M) at two different pHs (7.4 
and 5.0) at 37 °C (Figure 12 (a, b)). The pH of 
7.4 corresponds to the normal environment of 
body tissue and blood, while pH 5.0 is more 
appropriate for tumour-affected cells [21]. The 
drug-loaded MNV (CoFe2O4.NPs@XG-Doxo) did 
not show a significant release of Doxo at neutral 
pH 7.4 in the absence (13.5 %) as well as 
presence (32 %) of AMF after 120 h. In contrast, 
at pH 5.0, the discharge of drug was slow (ca. 15 
%) in the first 6 h, which increased to 39 % after 
120 h. However, an increased, controlled and 
regular release of drug up to 69% was observed 
in the presence of the external AMF after 120 h. 
 
 
Figure 10: Vibrating sample magnetometer graphs of uncoated (CoFe2O4.NPs) and XG-coated 
Cobalt ferrite NPs (CoFe2O4.NPs@XG) 
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Figure 11: CoFe2O4.NPs suspension (a); which is exhibiting magnetic response towards a magnet (b) 
 
    
Figure 12:  Drug release profile in the absence (■) and presence (●) of externally applied magnetic field (AMF) at 
(a) pH ∼ 7.4; (b) pH ∼ 5.0 
 
In vitro toxicity of CoFe2O4.NPs@XG 
 
The MTT assay against the CHO and Huh7 cell 
lines was used to establish the in vitro toxicity of 
the XG-coated ferrite NPs. Figure 13 exhibits the 
cell viability profiles of the CHO and Huh7 cells 
incubated at various concentrations (0–2.0 
mg/mL) of MNV. After 48 h of dose exposure, 
cell viability exceeding 80 %, even at a high 
concentration (1.6 mg/mL), confirmed the 
biocompatibility of the CoFe2O4.NPs@XG. This 
is likely because XG is a food-grade 
polysaccharide whose degradation products are 
not toxic to the exposed cells. 
 
Pharmacological activity of 
CoFe2O4.NPs@XG-Doxo 
 
A 0–0.18 mg/mL dose of the drug-loaded MNA 
(CoFe2O4.NPs@XG-Doxo) was applied to Huh7 
cells over 48 h of incubation to investigate its 
pharmacological activity. Figure 14 reveals the 
significant decrease in the percentage cell 
viability with increasing concentration of the 
magnetic nanoassembly. More than 50 % of the 
cells were dead even at the low concentration of 
0.16 mg/mL. This marked decrease in cell 
viability was attributed to the anti-proliferative 




The UV-vis absorption band in the range of 330–
500 nm was attributed to the homogenised 
electronic motion of the CFNPs. Generally, metal 
nanoparticles display a characteristic plasmon 
resonance band in their UV-vis absorbance 
spectra due to the collective resonance of their 
conduction electrons [19]. Peaks in the range of 
400–600 cm−1 for metal ferrite NPs indicate the 
presence of a metal–oxygen bond. The splitting 
of the low-frequency band for the octahedral site 
(B) reveals the presence of different metal ions 
including Fe3+, Fe2+ and Co2+.  
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Figure 13: Pharmacological activity of xanthan gum coated CoFe2O4.NPs@XG against CHO and Huh 7 cells   
           
 
Figure 14: Pharmacological activity of doxorubicin loaded CFNPs (CoFe2O4.NPs@XG-Doxo) against Huh 7 
 
However, the slight shifting of the M–O peaks of 
the coated CFNPs was attributed to the 
polymeric XG layer. The broad absorption band 
at 3350–3500 cm−1 was assigned to the 
stretching vibration of the –OH group. The 
splitting of the peaks at 2950–3250 and 1547 
cm−1 corresponds to the N–H stretching and N–H 
bending vibrations, respectively, of the secondary 
amide group. Briefly, the FT-IR spectrum of the 
loaded drug (Figure 3c) revealed drug adsorption 
in two ways: first, by the partial interaction 
between the XG carboxylate (COO−) and amine 
(–NH2) groups of the drug via amide formation 
and, second, by the –OH vibrational bands [21]. 
 
The percentage weight loss determined by TGA 
of the pure CFNPs was attributed to the 
evaporation of absorbed water and ethanol from 
the nanoferrite powder surface. Such a small 
change in mass was consistent with the pure 
spinel phase of the CFNPs. The mass loss of the 
XG-coated CFNPs was mostly observed in two 
regions. The first mass loss was due to the loss 
of loosely bound water molecules and the coated 
layer of polymer. However, the second step of a 
sharp mass loss corresponded to the combustion 
of the polymer coating from the NP surface [22]. 
 
Coating with XG is an effective way to reduce the 
hydrophobicity of ferrites and increase their water 
dispersibility. Indeed, the presence of abundant 
hydroxyl (–OH) and carboxyl (–COOH) groups in 
XG increases the porosity and surface energy of 
XG-coated magnetic NPs, and increases their 
hydrophilicity [23]. 
 
The XRD spectra of the native CFNPs 
(CoFe2O4.NPs) confirmed their crystalline nature 
with the inverse spinel structure and the space 
group Fd3m,Oh. The absence of hkl planes of 
iron or cobalt oxides (Fe2O3, Fe3O4, CoO) 
indicated the purity of the synthesised CFNPs 
[24]. However, the negligible crystallinity 
observed for the CoFe2O4.NPs@XG was caused 
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by the amorphous layer of XG that coated the 
CFNPs.  
 
SEM images of the uncoated CFNPs revealed 
some agglomeration that was attributed to van 
der Waals forces and dipole-dipole magnetic 
attractions [25]. However, the XG-coated CFNPs 
were less agglomerated and had lower 
polydespersity.  
 
The absence of a hysteresis loop, and negligible 
remanence (Mr) and coercivity (Hc) reflected the 
superparamagnetic behaviour of the CFNPs. The 
lower Ms value of the coated CFNPs 
(CoFe2O4.NPs@XG) may be correlated with 
various factors such as the low mass and small 
size of the magnetic core and the presence of 
the magnetically inactive XG layer, which 
reduced the exchange coupling energy of the 
magnetic field [26]. Additionally, the high 
magnetisation value of the native CFNPs 
reflected their uniform distribution and small 




Superparamagnetic nanocrystals of cobalt ferrite 
has been readily synthesised by co-precipitation 
with their surface was modified by XG, a food-
grade hydrophilic polymer. Various analyses 
confirmed the presence of M‒O bond and 
bonding of XG functional groups to the surface of 
the CFNPs. The superparamagnetic behaviour 
(negligible coercivity, remanence and hysteresis 
at 300 K) of the bare CFNPs is preserved in the 
XG-coated CFNPs (CoFe2O4.NPs@XG), which 
suggests its potential as an MNV for anti-cancer 
drugs. Significantly enhanced release of Doxo 
from CoFe2O4.NPs@XG-Doxo in the presence of 
an AMF has been achieved. The XG-coated 
CFNPs are biocompatible while the drug-loaded 
MNV assembly, CoFe2O4.NPs@XG-Doxo, 
efficiently inhibits cell viability, which suggests 
intracellular uptake of Doxo by Huh7 cancer 
cells. Thus, surface modification of CFNPs with 
XG is a novel technique to obtain a 







This research was conducted with funding 
provided by the Higher Education Commission 
(HEC) of Pakistan. The authors acknowledge the 
support of Dr Bushra Ijaz and other staff 
members of the Centre of Excellence in 
Molecular Biology (CEMB), University of the 
Punjab, Lahore, Pakistan. 
Conflict of Interest 
 
No conflict of interest associated with this work. 
 
Contribution of Authors 
 
The authors declare that this work was done by 
the authors named in this article and all liabilities 
pertaining to claims relating to the content of this 
article will be borne by them.  
 
Open Access  
 
This is an Open Access article that uses a fund-
ing model which does not charge readers or their 
institutions for access and distributed under the 
terms of the Creative Commons Attribution 
License (http://creativecommons.org/licenses/by/ 
4.0) and the Budapest Open Access Initiative 
(http://www.budapestopenaccessinitiative.org/rea
d), which permit unrestricted use, distribution, 
and reproduction in any medium, provided the 




1. Guo W, Wu L, Chen Z, Boschloo G, Hagfeldt A, Ma T. 
Highly efficient dye-sensitised solar cells based on 
nitrogen-doped titania with excellent stability. J. 
Photochem. Photobiol. A: Chem. 2011; 219: 180–187. 
2. Huang J, Zhong X, Wang L, Yang L, Mao H. Improving 
the magnetic resonance imaging contrast and detection 
methods with engineered magnetic nanoparticles. 
Theranostics 2012; 2: 86. 
3. Yan CH, Xu ZG, Cheng F X, Wang ZM, Sun LD, Liao CS, 
Jia JT. Nanophased CoFe2O4 prepared by combustion 
method. Solid State Commun. 1999; 111: 287–291. 
4. Moumen N, Veillet P, Pileni M. Controlled preparation of 
nanosize cobalt ferrite magnetic particles. J. Magn. 
Magn. Mater. 1995; 149: 67–71. 
5. Ngo AT, Bonville P, Pileni MP. Synthesis and 
superparamagnetic properties of Nanoparticles. Eur. 
Phys. J. B - Condensed Matter and Complex Systems 
1999; 9: 583–592. 
6. Dey S, Ghose J. Synthesis, characterisation and 
magnetic studies on nanocrystalline Co0.2Zn0.8Fe2O4. 
Mater. Res. Bull. 2003; 38: 1653–1660. 
7. Sathaye SD, Patil KR, Kulkarni SD, Bakre PP, Pradhan 
SD, Sarwade BD, Shintre SN. Modification of spin 
coating method and its application to grow thin films of 
cobalt ferrite. J. Mater. Sci. 2003; 38: 29–33. 
8. Sorescu M, Diamandescu L, Peelamedu, R, Roy R, 
Yadoji P. Structural and magnetic properties of Nisn 
ferrites prepared by microwave sintering. J. Magn. 
Magn. Mater. 2004; 279: 195–201. 
9. Mathieu A, Lotfi Ben T, Frederic H, Leila S, Francoise V, 
Nader Y, Jean-Marc G, Souad A, Fernand F. Sise-
dependent magnetic properties of CoFe2O4 
Mushtaq et al 
Trop J Pharm Res, July 2017; 16(7): 1674  
 
nanoparticles prepared in polyol. J. Phys. Condens. 
Matter 2011; 23: 506001. 
10. Davis SS. Biomedical applications of nanotechnology-
implications for drug targeting and gene therapy. Trends 
Biotechnol. 1997; 15: 217–24. 
11. Nappini S, Magnano E, Bondino F, Pis I, Barla A, 
Fantechi E, Pineider F, Sangregorio C, Vaccari, L, 
Venturelli L. Surface charge and coating of CoFe2O4 
nanoparticles: Evidence of preserved magnetic and 
electronic properties. J. Phys. Chem. C 2015; 119: 
25529–25541. 
12. Salunkhe AB, Khot VM, Thorat ND, Phadatare MR, 
Sathish CI, Dhawale DS, Pawar SH.  Polyvinyl alcohol 
functionalised cobalt ferrite nanoparticles for biomedical 
applications. Appl. Surf. Sci. 2013; 264: 598–604. 
13. Mushtaq MW, Kanwal F, Bashir S, Imran M, Synthesis, 
Characterisation and biological studies of cobalt ferrite 
nanoparticles. Bul. Chem. Commun. 2016; 48: 565–570. 
14. Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, 
Goganian AM, Khiabani HK, Samiei M, Davaran S, 
Synthesis, characterisation and in vitro evaluation of 
novel polymer-coated magnetic nanoparticles for 
controlled delivery of doxorubicin. Nanotechnol. Sci. 
Appl. 2012; 5: 13–25. 
15. Wang G, Ma Y, Mu J, Zhang Z, Zhang X, Zhang L, Che 
H, Bai Y, Hou J, Xie H. Monodisperse 
polyvinylpyrrolidone-coated CoFe2O4 nanoparticles: 
Synthesis, characterisation and cytotoxicity study. Appl. 
Surf. Sci. 2016; 365: 114–119. 
16. Mahmoudi M, Simchi A, Imani M, Milani AS, Stroeve P. 
Optimal design and characterisation of 
superparamagnetic iron oxide nanoparticles coated with 
polyvinyl alcohol for targeted delivery and imaging. J. 
Phys. Chem. B 2008; 112: 14470–14481. 
17. Aronniemi M, Lahtinen J, Hautojarvi P. Characterisation 
of iron oxide thin films. Surf. Interface Anal. 2004; 36: 
1004–1006. 
18. Che E, Wan L, Zhang Y, Zhao Q, Han X, Li J, Liu J, 
Wang S. Development of phosphonate-terminated 
magnetic mesoporous silica nanoparticles for pH-
controlled release of doxorubicin and improved tumour 
accumulation. Asian J. Pharm. Sci. 2014; 9: 317–323. 
19. Wong HL, Rauth AM, Bendayan R, Manias JL, 
Ramaswamy M, Liu Z, Erhan SZ, Wu XY. A new 
polymer-lipid hybrid nanoparticle system increases 
cytotoxicity of doxorubicin against multidrug-resistant 
human breast cancer cells. Pharm. Res. 2006; 23: 
1574–1585. 
20. Arsalani N, Fattahi H, Nazarpoor M, Synthesis and 
characterisation of PVP-functionalised 
superparamagnetic Fe3O4 nanoparticles as an MRI 
contrast agent. Express Polym. Lett. 2010; 4: 329–338.  
21. Zhang Y, Das GK, Xu R, Yang Tan TT. Tb-doped iron 
oxide: bifunctional fluorescent and magnetic 
nanocrystals. J. Mater. Chem. 2009; 19: 3696–3703. 
22. Liu G, Hong RY, Guo L, Li YG, Li HZ. Preparation, 
characterisation and MRI application of carboxymethyl 
dextran coated magnetic nanoparticles. Appl. Surf. Sci. 
2011; 257: 6711–6717. 
23. Huang Z, Zhu Y, Zhang J, Yin G. Stable biomimetic super 
hydrophobicity and magnetisation film with Cu-ferrite 
nanorods. J. Phys. Chem. C 2007; 111: 6821–6825. 
24. Khandekar MS, Kambale RC, Patil JY, Kolekar YD, 
Suryavanshi SS. Effect of calcination temperature on 
the structural and electrical properties of cobalt ferrite 
synthesised by combustion method. J. Alloys Compd. 
2011; 509: 1861–1865. 
25. Zhang X, Guo Q, Cui D. Recent advances in 
nanotechnology applied to biosensors. Sensors 2009; 9: 
1033–1053. 
26. Raghavender A. Synthesis and characterisation of cobalt 
ferrite nanoparticles. Sci. Technol. Arts Res. J. 2014; 2: 
1–4. 
 
